Europe Acetaminophen Reagents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Antibody/Substrate Reagent, Enzyme Reagent, Acetaminophen Antiserum, Acetaminophen Fluorescein Tracer, and Pretreatment Solution), Application (Enzymatic Assays and Immunoassay), and End User (Hospitals, Diagnostics Laboratories, POC Testing, Forensic Laboratories, and Others)

The Europe acetaminophen reagents market is expected to grow from US$ 164.88 million in 2021 to US$ 222.79 million by 2028; it is estimated to grow at a CAGR of 4.4% from 2021 to 2028.

Acetaminophen tests measure excess amount of drug content in blood to diagnose its overdose, assess the risk of liver damage, and help decide the need for treatment. Acetaminophen toxicity is diagnosed through various diagnostic tests, such as an acetaminophen level, electrolytes, kidney function tests, and liver function tests. Proper diagnosis of acetaminophen level and accurate treatment are essential for a positive outcome. Increasing usage of OTC acetaminophen in several symptomatic treatments increases the volume for acetaminophen testing. An acetaminophen test is required when a person is suspected of taking an overdose of acetaminophen or shows signs and symptoms of toxicity, such as vomiting, nausea, and abdominal pain. An overdose can be classified into four stages. Stage 1 occurs within 24 hours that is characterized by nausea, vomiting, and malaise. Stage 2 occurs within 24 to 27 hours and involves increased nausea and vomiting, pain in the upper right abdomen, and worsening hepatic and renal toxicity. In stage 3, liver function abnormalities peak between day 3 and day 4 and depending upon the degree of poisoning, hepatic failure with jaundice and bleeding diathesis can also occur, leading to multiorgan failure and death in this phase. Patients who survive stage 3 progress to stage 4 with a slow recovery and normalization of the liver between days 4 and day 7. Furthermore, several medical administrations takes various steps to reduce the acetaminophen maximum dosage unit strength in prescription drug products, such as safety labeling changes, including a new boxed warning, for acetaminophen-containing prescription drug products. It helps prevent liver damage that can occur due to acetaminophen overdose, a severe public health problem. Hence, drug level testing is performed to prevent severe damage to liver that also helps to suggests medication accordingly to provide efficient treatment to the patients.  Therefore, as the acetaminophen reagents are specific drug testing reagents that help to determine the level of drug in the sample during the testing process, so the high adoption of acetaminophen testing (immunoassay testing) due to increased cases of overdoses and surged inclination toward OTC drugs drive the growth of the Europe acetaminophen reagents market.In case of COVID-19, Europe is highly affected specially the UK.  The European region is severely affected due to the exponential growth of the COVID-19 pandemic like other parts of the planet. As per the European Centre for Disease Prevention and Control (ECDC), bans have been reintroduced due to the second wave of COVID-19 crises in the UK, Spain, and Italy. The rising occurrence rate of coronavirus results in increased stress on the region's healthcare system, raising the demand for diagnostic tests in its healthcare system, supporting the expansion of the sector in this region.  The acetaminophen reagents market witnessed a shortfall at the beginning of the COVID-19 crisis due to disruption in the supply chain and slumped demand due to the lockdown announced by most European countries that caused disruptions in manufacturing and operations in the pharmaceutical sector. Additionally, appointments and operations have been delayed in many clinics around the world due to increasing cases, as approximately 40% of the diagnosed COVID-19 cases required hospitalization; and some critical cases were admitted to intensive care units (ICU). With the number of rising cases, there was a significant decrease in procedures due to a lack of healthcare resources. It also impacted the new product launches, impacting sales and growth of the market in the region. However, with the implementation of proper guidelines and protocols by the European Commission to reduce SARS-CoV-2 exposure and ease in restrictions on movement, the market is expected to grow in the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe acetaminophen reagents market. The Europe acetaminophen reagents market is expected to grow at a good CAGR during the forecast period. 

Europe Acetaminophen Reagents Market Revenue and Forecast to 2028 (US$ Million)  

Europe Acetaminophen Reagents Market Segmentation

Europe Acetaminophen Reagents Market – By Product

• Antibody/Substrate Reagent
• Enzyme Reagent 
• Acetaminophen Antiserum
• Acetaminophen Fluorescein Tracer
• Pretreatment Solution

Europe Acetaminophen Reagents Market – By Application

• Enzymatic Assays
• Immunoassay

Europe Acetaminophen Reagents Market – By End User

• Hospitals
• Diagnostics Laboratories
• POC Testing
• Forensic Laboratories 
• Others

Europe Acetaminophen Reagents Market, by Country

• Germany
• France 
• UK
• Italy
• Spain
• Rest of Europe

Europe Acetaminophen Reagents Market - Companies Mentioned

• Abbott
• American Screening Corporation, Inc.
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• Biorbyt Ltd.  
• EKF Diagnostics
• Randox Laboratories, Ltd.
• Sekisui Diagnostics
• Siemens Healthineers AG 
• Thermo Fisher Scientific Inc.  

Europe Acetaminophen Reagents Report Scope

1. Abbott
2. American Screening Corporation, Inc.
3. Beckman Coulter, Inc.
4. Bio-Rad Laboratories, Inc.
5. Biorbyt Ltd.
6. EKF Diagnostics
7. Randox Laboratories, Ltd.  
8. Sekisui Diagnostics
9. Siemens Healthineers AG
10. Thermo Fisher Scientific Inc.  

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe acetaminophen reagents market.       
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Europe acetaminophen reagents market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the acetaminophen reagents market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution